H/ACA ribonukleoproteinski kompleks podjednica 4 je protein koji je kod ljudi kodiran DKC1genom.[4][5][6]
Ovaj gen je član H/ACA snoRNPs familije gena (malih nukleolarnih ribonukleoproteina). snoRNP proteini učestvuju u raznim aspektima rRNK obrade i modifikacije. Oni se klasifikuju u dve familije: C/D i H/ACA. H/ACA snoRNP grupa takođe obuhvata NOLA1, 2 i 3 proteine. Protein kodiran ovim genom i tri NOLA proteina se lokalizuju u gustim fibrilarnim komponentama nukleola i u namotanim (Cajal) telima u nukleusu. Produkcija 18S rRNK i rRNK pseudouridilacija bivaju ometene ako se bilo koji od ova četiri proteina iscrpi. Protein kodiran ovim genom je srodan sa Saccharomyces cerevisiae Cbf5p i Drosophila melanogaster Nop60B proteinima.[6]
^Lim, B. C.; Yoo, S. K.; Lee, S; Shin, J. Y.; Hwang, H; Chae, J. H.; Hwang, Y. S.; Seo, J. S.; Kim, J. I.; Kim, K. J. (2014). „Hoyeraal-Hreidarsson syndrome with a DKC1 mutation identified by whole-exome sequencing”. Gene. 546 (2): 425—9. PMID24914498. doi:10.1016/j.gene.2014.06.011.
Marrone A, Dokal I (2004). „Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.”. Expert Reviews in Molecular Medicine. 6 (26): 1—23. PMID15613268. doi:10.1017/S1462399404008671.
Yamaguchi H (2007). „Mutations of telomerase complex genes linked to bone marrow failures.”. Journal of Nippon Medical School = Nihon Ika Daigaku zasshi. 74 (3): 202—9. PMID17625368. doi:10.1272/jnms.74.202.
Aalfs CM, van den Berg H, Barth PG, Hennekam RC (1995). „The Hoyeraal-Hreidarsson syndrome: the fourth case of a separate entity with prenatal growth retardation, progressive pancytopenia and cerebellar hypoplasia.”. Eur. J. Pediatr. 154 (4): 304—8. PMID7607282. doi:10.1007/BF01957367.
Maruyama K, Sugano S (1994). „Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.”. Gene. 138 (1–2): 171—4. PMID8125298. doi:10.1016/0378-1119(94)90802-8.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). „Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library”. Gene. 200 (1–2): 149—56. PMID9373149. doi:10.1016/S0378-1119(97)00411-3.
McGrath JA (1999). „Dyskeratosis congenita: new clinical and molecular insights into ribosome function”. Lancet. 353 (9160): 1204—5. PMID10217077. doi:10.1016/S0140-6736(99)00011-2.
Vulliamy TJ, Knight SW, Heiss NS, et al. (1999). „Dyskeratosis congenita caused by a 3' deletion: germline and somatic mosaicism in a female carrier”. Blood. 94 (4): 1254—60. PMID10438713.
Heiss NS, Girod A, Salowsky R, et al. (2000). „Dyskerin localizes to the nucleolus and its mislocalization is unlikely to play a role in the pathogenesis of dyskeratosis congenita”. Hum. Mol. Genet. 8 (13): 2515—24. PMID10556300. doi:10.1093/hmg/8.13.2515.
Knight SW, Heiss NS, Vulliamy TJ, et al. (2000). „Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1”. Br. J. Haematol. 107 (2): 335—9. PMID10583221. doi:10.1046/j.1365-2141.1999.01690.x.
Mitchell JR, Wood E, Collins K (1999). „A telomerase component is defective in the human disease dyskeratosis congenita”. Nature. 402 (6761): 551—5. PMID10591218. doi:10.1038/990141.
Yaghmai R, Kimyai-Asadi A, Rostamiani K, et al. (2000). „Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome”. J. Pediatr. 136 (3): 390—3. PMID10700698. doi:10.1067/mpd.2000.104295.
Heiss NS, Bächner D, Salowsky R, et al. (2000). „Gene structure and expression of the mouse dyskeratosis congenita gene, dkc1”. Genomics. 67 (2): 153—63. PMID10903840. doi:10.1006/geno.2000.6227.
Knight SW, Vulliamy TJ, Morgan B, et al. (2001). „Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis”. Hum. Genet. 108 (4): 299—303. PMID11379875. doi:10.1007/s004390100494.